John Crowley

Sales & Marketing

Neil Newhouse, Kathy Rice, Greg Walden, and Friz Bittenbender at BIO 2024

At BIO 2024, an industry vows to reclaim its narrative

At BIO2024 experts agreed that in a period where pharma is deeply unpopular, the industry must be proactive in telling its story.

News

FDA removes barriers to cell, gene therapy development

FDA wants to exert regulatory flexibility on cell and gene therapies in an effort to bring them to patients more quickly and efficiently.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks